Publications by authors named "Jennifer Cather"

Claim this Profile
A
A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up.
Jennifer Cather, Melodie Young, Douglas C DiRuggiero, Susan Tofte, Linda Williams

Dermatol Ther (Heidelb)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial.
Amy S Paller, Marieke M B Seyger, Gabriel A Magariños, Andreas Pinter, Jennifer C Cather

JAMA Dermatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixekizumab for the treatment of pediatric patients with moderate to severe plaque psoriasis.
Jennifer Clay Cather, Chaney T Young, Melody S Young, J Christian Cather

Expert Opin Biol Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabidiol primer for healthcare professionals.
Jennifer Clay Cather, J Christian Cather

Proc (Bayl Univ Med Cent)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.
Adelaide A Hebert, Dee Anna Glaser, Lawrence Green, Cheryl Hull, Jennifer Cather

Pediatr Dermatol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recapture Rate of Brodalumab in Patients With a Lapse in Treatment.
Mark Lebwohl, Jennifer Cather, April Armstrong, Abby Van Voorhees, Abby Jacobson

J Drugs Dermatol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study.
Gil Yosipovitch, Peter Foley, Caitriona Ryan, Jennifer C Cather, Kim A Meeuwis

J Sex Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual Health.
Alice B Gottlieb, Brian Kirby, Caitriona Ryan, April N Naegeli, Russel Burge, Jennifer Cather

Dermatol Ther (Heidelb)· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative Study.
Jennifer Clay Cather, Caitriona Ryan, Kim Meeuwis, Alison J Potts Bleakman, April N Naegeli

Dermatol Ther (Heidelb)· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2).
Jeffrey Crowley, Diamant Thaçi, Pascal Joly, Ketty Peris, Kim A Papp, Jennifer C Cather

J Am Acad Dermatol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Andrew Blauvelt, Marjolein de Bruin-Weller, Melinda Gooderham, Jennifer C Cather, Jamie Weisman

Lancet· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoriasis and Psoriatic Arthritis.
Jennifer Clay Cather, Melodie Young, Martin Jan Bergman

J Clin Aesthet Dermatol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies.
Alan Menter, Jennifer C Cather, Michael Jarratt, Xiangyi Meng, Adriana Guana

Dermatol Ther (Heidelb)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials.
M Alan Menter, Kim A Papp, Jennifer Cather, Craig Leonardi, David M Pariser

J Drugs Dermatol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of biologic agents in combination with other therapies for the treatment of psoriasis.
Jennifer C Cather, Jeffrey J Crowley

Am J Clin Dermatol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoriasis in children and women: addressing some special needs.
Jennifer C Cather

Semin Cutan Med Surg· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the 5th annual perspectives in rheumatic diseases.
Daniel E Furst, Brian Mandell, Leonard H Calabrese, Jennifer C Cather, Daniel J Clauw

Semin Arthritis Rheum· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pralatrexate (Folotyn).
William Abramovits, Marcial Oquendo, Patricia Granowski, Aditya Gupta, Jennifer Cather

Skinmed· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial.
Kim Papp, Jennifer C Cather, Les Rosoph, Howard Sofen, Richard G Langley

Lancet· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients.
Melodie S Young, Elizabeth J Horn, Jennifer C Cather

Expert Rev Clin Immunol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blanched fingers.
Anna P Meier, Jennifer Clay Cather

Proc (Bayl Univ Med Cent)· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach.
Bruce Strober, Emily Berger, Jennifer Cather, David Cohen, Jeffrey J Crowley

J Am Acad Dermatol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AJC editor's consensus: psoriasis and coronary artery disease.
Vincent E Friedewald, Jennifer C Cather, Joel M Gelfand, Kenneth B Gordon, Gary H Gibbons

Am J Cardiol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymptomatic translucent dome-shaped cystic nodule on the finger.
Jennifer C Cather

Proc (Bayl Univ Med Cent)· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The editor's roundtable: psoriasis, inflammation, and coronary artery disease.
Vincent E Friedewald, Jennifer C Cather, Kenneth B Gordon, Arthur Kavanaugh, Paul M Ridker

Am J Cardiol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis